Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.
Saved in:
| Title: | Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression. |
|---|---|
| Authors: | Shimizu T; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Ohkuma R; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Homma M; Department of Pathology, Showa Medical University School of Medicine, Tokyo, Japan., Nakayama S; Department of Pathology, Showa Medical University School of Medicine, Tokyo, Japan., Sasaki Y; Department of Pathology, Showa Medical University School of Medicine, Tokyo, Japan., Muto S; Department of Chest Surgery, School of Medicine, Fukushima Medical University, Fukushima, Japan., Ieguchi K; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Watanabe M; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, School of Medicine, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Taguchi A; Isotope Science Center, The University of Tokyo, Tokyo, Japan., Takayanagi D; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Wada Y; Isotope Science Center, The University of Tokyo, Tokyo, Japan., Horiike A; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Ariizumi H; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Shimokawa M; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Hirasawa Y; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Ishiguro T; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Suzuki R; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Iriguchi N; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Mura E; Division of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan., Yoshimura K; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Chest Surgery, School of Medicine, Fukushima Medical University, Fukushima, Japan., Tsuji M; Department of Pharmacology, School of Medicine, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Kiuchi Y; Department of Pharmacology, School of Medicine, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Showa Medical University College of Nursing, Tokyo, Japan., Suzuki H; Department of Chest Surgery, School of Medicine, Fukushima Medical University, Fukushima, Japan., Yamochi T; Department of Pathology, Showa Medical University School of Medicine, Tokyo, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 26; Vol. 17, pp. 1827736. Date of Electronic Publication: 2026 Mar 26 (Print Publication: 2026). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1827736 |
